Apnimed, Inc. shares third-quarter results, showcasing growth and advancements in pharmaceutical preparations, positioning itself competitively in the industry.
| Name | Apnimed, Inc. |
|---|---|
| CIK | 0001745648 |
| Tickers | APMD |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 821910611 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-500-8880 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Apnimed, Inc. shares third-quarter results, showcasing growth and advancements in pharmaceutical preparations, positioning itself competitively in the industry.
Apnimed, Inc. shares its latest financial results and operational updates, signaling important developments in the pharmaceutical preparations sector.
Apnimed, Inc. has filed an amended quarterly report, providing updated financial information for Q2 2026, impacting stakeholders and the pharmaceutical industry.
Shionogi & Co. Ltd. has acquired a 7.1% stake in Apnimed, Inc., signaling increased interest in the pharmaceutical preparations sector.
61 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-463732 | 005-95843 | 261562323 | 34 | 7402 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-004928 | 005-95843 | 261561186 | 34 | 33405 | |||
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462185 | 001-43422 | 261555588 | 34 | 15758385 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-462171 | 001-43422 | 261555562 | 34 | 594429 | 1 | 1 |
| 2026-11-13 | 10-Q/A | 10-Q/A | 0001193125-26-460871 | 001-43422 | 261553600 | 34 | 16343851 | 1 | 1 | |
| 2026-11-13 | 8-K | 8-K | 4.02 | 0001193125-26-460864 | 001-43422 | 261553546 | 34 | 192776 | 1 | 1 |
| 2026-11-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000947871-26-000976 | 005-95843 | 261520302 | 34 | 6673 | |||
| 2026-09-08 | S-8 | S-8 | 0001193125-26-385357 | 333-298803 | 261365858 | 33 | 514853 | 1 | 1 | |
| 2026-09-08 | 10-Q | 10-Q | 0001193125-26-385356 | 001-43422 | 261365850 | 34 | 15439916 | 1 | 1 | |
| 2026-09-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-385355 | 001-43422 | 261365845 | 34 | 619128 | 1 | 1 |
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-340067 | 005-95843 | 261253539 | 34 | 228498 | |||
| 2026-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-092032 | 005-95843 | 261249291 | 34 | 19315 | |||
| 2026-08-05 | 4 | FORM 4 | 0000905148-26-003483 | 21504 | ||||||
| 2026-08-05 | 4 | xslF345X06/ownership.xml | 0000919574-26-004812 | 28730 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330510 | 14025 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330505 | 18573 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330508 | 18767 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330504 | 18756 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330507 | 21784 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330503 | 9752 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330506 | 62623 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-330502 | 42747 | ||||||
| 2026-08-03 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-330509 | 001-43422 | 261232678 | 34 | 324953 | ||
| 2026-07-31 | S-8 | S-8 | 0001193125-26-328744 | 333-297900 | 261229112 | 33 | 403288 | 1 | 1 | |
| 2026-07-31 | 424B4 | 424B4 | 0001193125-26-328422 | 333-297377 | 261228347 | 33 | 25469556 | |||
| 2026-07-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002498 | 333-297377 | 261225217 | 33 | 1722 | ||
| 2026-07-30 | 3 | FORM 3 | 0000905148-26-003420 | 8641 | ||||||
| 2026-07-30 | S-1MEF | S-1MEF | 0001193125-26-326515 | 333-297849 | 261224998 | 33 | 267788 | 1 | 1 | |
| 2026-07-30 | 3 | xslF345X06/ownership.xml | 0000919574-26-004695 | 17835 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326266 | 25447 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326255 | 17018 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326223 | 15862 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326218 | 19206 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326210 | 17714 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326204 | 16196 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326202 | 16701 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326201 | 6037 | ||||||
| 2026-07-30 | 3 | 3 | 0001193125-26-326188 | 33149 | ||||||
| 2026-07-30 | CERT | APMD_8A_Cert_0001745648.pdf | 0001354457-26-000743 | 001-43422 | 261221650 | 34 | 116309 | |||
| 2026-07-29 | 8-A12B | 8-A12B | 0001193125-26-322198 | 001-43422 | 261214009 | 34 | 31643 | |||
| 2026-07-27 | S-1/A | S-1/A | 0001193125-26-316811 | 333-297377 | 261202787 | 33 | 27769697 | 1 | 1 | |
| 2026-07-10 | S-1 | S-1 | 0001193125-26-300909 | 333-297377 | 261168893 | 33 | 33022475 | 1 | 1 | |
| 2026-06-01 | DRS/A | filename1.htm | 0001193125-26-249229 | 377-07317 | 261046832 | 33 | 10531859 | |||
| 2026-04-22 | DRS/A | filename1.htm | 0001193125-26-167732 | 377-07317 | 26881044 | 33 | 11050672 | |||
| 2026-03-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-26-000001 | 021-578027 | 26800665 | 33 | 14066 | ||
| 2026-02-17 | DRS/A | filename1.htm | 0001193125-26-054701 | 377-07317 | 26641590 | 33 | 7393320 | |||
| 2025-12-08 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-25-000005 | 021-558476 | 251555677 | 33 | 14069 | ||
| 2025-10-01 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-25-000004 | 021-558476 | 251362845 | 33 | 13997 | ||
| 2025-09-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-25-000003 | 021-558476 | 251335637 | 33 | 13912 | ||
| 2025-04-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001879785-25-000026 | 021-544389 | 25865263 | 33 | 13076 | ||
| 2024-07-01 | DRS | filename1.htm | 0000950123-24-006348 | 377-07317 | 241091238 | 33 | 12840238 | |||
| 2023-11-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-23-000001 | 021-496807 | 231387477 | 33 | 12053 | ||
| 2022-12-23 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-22-000003 | 021-468579 | 221483979 | 33 | 11992 | ||
| 2022-11-01 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-22-000002 | 021-445175 | 221350061 | 33 | 12851 | ||
| 2022-05-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-22-000001 | 021-445175 | 22909699 | 33 | 12004 | ||
| 2021-03-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-21-000001 | 021-393539 | 21771985 | 33 | 10006 | ||
| 2020-04-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-20-000001 | 021-364430 | 20778689 | 33 | 9957 | ||
| 2019-08-07 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-19-000008 | 021-316175 | 191006115 | 33 | 9743 | ||
| 2019-01-10 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-19-000001 | 021-316175 | 19519575 | 33 | 9756 | ||
| 2018-08-09 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001745648-18-000002 | 021-316175 | 181003994 | 33 | 9757 | ||
| 2018-07-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001745648-18-000001 | 021-316175 | 18942210 | 33 | 9617 |
One latest value per concept from companyfacts (160 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 41.63M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 9,145.67 | 2026-09-08 | S-8 | 2026-09-08 | 0001193125-26-385357 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 9,145.67 | 2026-09-08 | S-8 | 2026-09-08 | 0001193125-26-385357 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 66.22M | 2026-09-08 | S-8 | 2026-09-08 | 0001193125-26-385357 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-08 | S-8 | 2026-09-08 | 0001193125-26-385357 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-07-30 | S-1MEF | 2026-07-30 | 0001193125-26-326515 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 15.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 588,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 5.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 71,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 517.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 6.27M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 8.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 32.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | Assets | Assets | USD | 371.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 360.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | AssetsHeldForSaleLongLivedFairValueDisclosure | Assets Held-for-sale, Long Lived, Fair Value Disclosure | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 351.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 352.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 310.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 36.50M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 11.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 41.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 41.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 245.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 39.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 35.00M | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 3.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 39.33M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DebtConversionConvertedInstrumentRate | Debt Conversion, Converted Instrument, Rate | pure | 0.1 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 2.65M | 2026-08-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 39.30M | 2026-08-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 35.00M | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 2.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 4.78M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 17.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 17.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 93.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DepositLiabilityCurrent | Deposit Liability, Current | USD | 57.10M | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | Depreciation | Depreciation | USD | 20,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share | USD/shares | 6.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share | USD/shares | 4.88 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | 85.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 13 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 9.63 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 6.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 40.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | EquityMethodInvestmentAggregateCost | Equity Method Investment, Aggregate Cost | USD | 26.90M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | EquityMethodInvestmentOtherThanTemporaryImpairment | Equity Method Investment, Other than Temporary Impairment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EquityMethodInvestmentRealizedGainLossOnDisposal | Equity Method Investment, Realized Gain (Loss) on Disposal | USD | 85.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 34.80M | 2024-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | FairValueOptionCreditRiskGainsLossesOnAssets | Fair Value, Option, Credit Risk, Gains (Losses) on Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 41.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | 81.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 81.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | 6.46 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | 4.75 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -2.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 17.21 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 2.57 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 82.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -371,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -95.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInDepositsOutstanding | Increase (Decrease) in Deposits Outstanding | USD | 57.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -186,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 4.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 5.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 340,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 4.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 2.95M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfPreferredStock | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock | shares | 21.14M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 752,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 78,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 27,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 328,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 319,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 65,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | Liabilities | Liabilities | USD | 86.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 371.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 36.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 39.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 269.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 99.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -59.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 164.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | 193.65M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | 192.34M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic | USD | 81.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted | USD | 80.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic | USD | 82.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted | USD | 82.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 57.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OciEquityMethodInvestmentAfterTax | OCI, Equity Method Investment, after Tax | USD | 62.20M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 75.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 24.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 687,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 273,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 414,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 652,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.081 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 166,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 24,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | OtherIncome | Other Income | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -2.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 6.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 249.52M | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 6.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 1.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 21.90M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 25.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 48.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 245.94M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 815,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 150.00M | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ProceedsFromRepurchaseOfRedeemablePreferredStock | Proceeds from (Repurchase of) Redeemable Preferred Stock | USD | 248.75M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ProceedsFromSaleOfEquityMethodInvestments | Proceeds from Sale of Equity Method Investments | USD | 100.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 79,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 117,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 46,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 29.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 352.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 500,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -233.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | Revenues | Revenues | USD | 99.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 8.60M | 2018-06-19 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 300,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q/A | 2026-11-13 | 0001193125-26-460871 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 8.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 4.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 284.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 245.94M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 198.90M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 18,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | SupplementalUnemploymentBenefitsSeveranceBenefits | Supplemental Unemployment Benefits, Severance Benefits | USD | 70,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 249.52M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 29.56M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 28.52M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 28.52M | 2026-08-03 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 16.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 12.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462185 |